FDA label e0e2f05d-7e90-5789-e053-2a95a90a4fce
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- 35c8037f-2601-4bd3-b423-2f53af7c0be3
- SPL ID
- e0e2f05d-7e90-5789-e053-2a95a90a4fce
- Version
- 9
- Effective date
- 2022-06-07
- Source export date
- 2026-10-12
- Source partition
- 1
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/7928c8e8c6256620071a8b7e5b93eb8dfa543649c08d17a01ea02251012ba58c/drug-label-0001-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 01:26:31
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | e0e2f05d-7e90-5789-e053-2a95a90a4fce | id | |
| spl set id | 35c8037f-2601-4bd3-b423-2f53af7c0be3 | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
5 WARNINGS AND PRECAUTIONS In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events occurred with anastrozole use compared to tamoxifen use. Consider risks and benefits. ( 5.1 , 6.1 ) Decreases in bone mineral density may occur. Consider bone mineral density monitoring. ( 5.2 , 6.1 ) Increases in total cholesterol may occur. Consider cholesterol monitoring. ( 5.3 , 6.1 ) Embryo-Fetal Toxicity: Anastrozole may cause fetal harm. Advise patients of the potential risk to a fetus and to use effective contraception. ( 5.4 , 8.1 ) 5.1 Ischemic Cardiovascular Events In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events was observed with anastrozole in the ATAC trial (17% of patients on anastrozole and 10% of patients on tamoxifen). Consider risk and benefits of anastrozole therapy in patients with pre-existing ischemic heart disease [ see Adverse Reactions (6.1) ]. 5.2 Bone Effects Results from the ATAC trial bone substudy at 12 and 24 months demonstrated that patients receiving anastrozole tablets had a mean decrease in both lumbar spine and total hip bone mineral density (BMD) compared to baseline. Patients receiving tamoxifen had a mean increase in both lumbar spine and total hip BMD compared to baseline. Consider bone mineral density monitoring in patients treated with anastrozole [ see Adverse Reactions (6.1) ]. 5.3 Cholesterol During the ATAC trial, more patients receiving anastrozole were reported to have elevated serum cholesterol compared to patients receiving tamoxifen (9% versus 3.5%, respectively) [ see Adverse Reactions (6.1) ]. 5.4 Embryo-Fetal Toxicity Based on findings from animal studies and its mechanism of action, anastrozole can cause fetal harm when administered to a pregnant woman. Anastrozole caused embryo-fetal toxicities in rats at maternal exposure that were 9 times the human clinical exposure, based on area under the curve (AUC). In rabbits, anastrozole caused pregnancy failure at doses equal to or greater than 16 times the recommended human dose on a mg/m 2 basis. Advise pregnant women and females of reproductive potential of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during therapy with anastrozole and for at least 3 weeks after the last dose [see Use in Specific Populations ( 8.1 , 8.3 ) and Clinical Pharmacology ( 12.1 )].
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions table
<table width="90%"><caption>Table 4 – Number of Patients with Pre-specified Adverse Reactions in Trials 0030 and 0027</caption><col width="30%"/><col width="30%"/><col width="30%"/><thead><tr><td align="left" valign="top"/><td align="center" colspan="2" valign="top"><paragraph><content styleCode="bold">Number (n) and Percentage of Patients</content></paragraph></td></tr><tr><td align="left" valign="top"><paragraph><content styleCode="bold">Adverse Reaction <footnote ID="K3212">A patient may have had more than 1 adverse reaction.</footnote></content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">Anastrozole</content></paragraph><paragraph><content styleCode="bold">1 mg</content></paragraph><paragraph><content styleCode="bold">(N = 506)</content></paragraph><paragraph><content styleCode="bold">n (%)</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">NOLVADEX</content></paragraph><paragraph><content styleCode="bold">20 mg</content></paragraph><paragraph><content styleCode="bold">(N = 511)</content></paragraph><paragraph><content styleCode="bold">n (%)</content></paragraph></td></tr></thead><tbody><tr><td align="left" valign="top"><paragraph>Depression</paragraph></td><td align="left" valign="top"><paragraph>23 (5)</paragraph></td><td align="left" valign="top"><paragraph>32 (6)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Tumor Flare</paragraph></td><td align="left" valign="top"><paragraph>15 (3)</paragraph></td><td align="left" valign="top"><paragraph>18 (4)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Thromboembolic Disease <footnote ID="table4">Includes pulmonary embolus, thrombophlebitis, retinal vein thrombosis.</footnote></paragraph></td><td align="left" valign="top"><paragraph>18 (4)</paragraph></td><td align="left" valign="top"><paragraph>33 (6)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph> Venous <footnoteRef IDREF="table4"/></paragraph></td><td align="left" valign="top"><paragraph>5</paragraph></td><td align="left" valign="top"><paragraph>15</paragraph></td></tr><tr><td align="left" valign="top"><paragraph> Coronary and Cerebral <footnote ID="K3328">Includes myocardial infarction, myocardial ischemia, angina pectoris, cerebrovascular accident, cerebral ischemia and cerebral infarct.</footnote></paragraph></td><td align="left" valign="top"><paragraph>13</paragraph></td><td align="left" valign="top"><paragraph>19</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Gastrointestinal Disturbance</paragraph></td><td align="left" valign="top"><paragraph>170 (34)</paragraph></td><td align="left" valign="top"><paragraph>196 (38)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Hot Flushes</paragraph></td><td align="left" valign="top"><paragraph>134 (26)</paragraph></td><td align="left" valign="top"><paragraph>118 (23)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Vaginal Dryness</paragraph></td><td align="left" valign="top"><paragraph>9 (2)</paragraph></td><td align="left" valign="top"><paragraph>3 (1)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Lethargy</paragraph></td><td align="left" valign="top"><paragraph>6 (1)</paragraph></td><td align="left" valign="top"><paragraph>15 (3)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Vaginal Bleeding</paragraph></td><td align="left" valign="top"><paragraph>5 (1)</paragraph></td><td align="left" valign="top"><paragraph>11 (2)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Weight Gain</paragraph></td><td align="left" valign="top"><paragraph>11 (2)</paragraph></td><td align="left" valign="top"><paragraph>8 (2)</paragraph></td></tr></tbody></table>
adverse reactions table
<table width="90%"><caption>Table 5 – Number (n) and Percentage of Patients with Adverse Reactions in Trials 0004 and 0005</caption><col width="20%"/><col width="10%"/><col width="10%"/><col width="10%"/><col width="10%"/><col width="10%"/><col width="10%"/><thead><tr><td align="left" rowspan="4" valign="top"><paragraph><content styleCode="bold">Adverse Reaction <footnote ID="K3473">A patient may have had more than one adverse reaction.</footnote></content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">Anastrozole</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">Anastrozole</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">Megestrol Acetate</content></paragraph></td></tr><tr><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">1 mg</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">10 mg</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">160 mg</content></paragraph></td></tr><tr><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">(N = 262)</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">(N = 246)</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">(N = 253)</content></paragraph></td></tr><tr><td align="left" valign="top"><paragraph><content styleCode="bold">n</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">%</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">n</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">%</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">n</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">%</content></paragraph></td></tr></thead><tbody><tr><td align="left" valign="top"><paragraph>Asthenia</paragraph></td><td align="left" valign="top"><paragraph>42</paragraph></td><td align="left" valign="top"><paragraph>(16)</paragraph></td><td align="left" valign="top"><paragraph>33</paragraph></td><td align="left" valign="top"><paragraph>(13)</paragraph></td><td align="left" valign="top"><paragraph>47</paragraph></td><td align="left" valign="top"><paragraph>(19)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Nausea</paragraph></td><td align="left" valign="top"><paragraph>41</paragraph></td><td align="left" valign="top"><paragraph>(16)</paragraph></td><td align="left" valign="top"><paragraph>48</paragraph></td><td align="left" valign="top"><paragraph>(20)</paragraph></td><td align="left" valign="top"><paragraph>28</paragraph></td><td align="left" valign="top"><paragraph>(11)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Headache</paragraph></td><td align="left" valign="top"><paragraph>34</paragraph></td><td align="left" valign="top"><paragraph>(13)</paragraph></td><td align="left" valign="top"><paragraph>44</paragraph></td><td align="left" valign="top"><paragraph>(18)</paragraph></td><td align="left" valign="top"><paragraph>24</paragraph></td><td align="left" valign="top"><paragraph>(9)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Hot Flashes</paragraph></td><td align="left" valign="top"><paragraph>32</paragraph></td><td align="left" valign="top"><paragraph>(12)</paragraph></td><td align="left" valign="top"><paragraph>29</paragraph></td><td align="left" valign="top"><paragraph>(11)</paragraph></td><td align="left" valign="top"><paragraph>21</paragraph></td><td align="left" valign="top"><paragraph>(8)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Pain</paragraph></td><td align="left" valign="top"><paragraph>28</paragraph></td><td align="left" valign="top"><paragraph>(11)</paragraph></td><td align="left" valign="top"><paragraph>38</paragraph></td><td align="left" valign="top"><paragraph>(15)</paragraph></td><td align="left" valign="top"><paragraph>29</paragraph></td><td align="left" valign="top"><paragraph>(11)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Back Pain</paragraph></td><td align="left" valign="top"><paragraph>28</paragraph></td><td align="left" valign="top"><paragraph>(11)</paragraph></td><td align="left" valign="top"><paragraph>26</paragraph></td><td align="left" valign="top"><paragraph>(11)</paragraph></td><td align="left" valign="top"><paragraph>19</paragraph></td><td align="left" valign="top"><paragraph>(8)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Dyspnea</paragraph></td><td align="left" valign="top"><paragraph>24</paragraph></td><td align="left" valign="top"><paragraph>(9)</paragraph></td><td align="left" valign="top"><paragraph>27</paragraph></td><td align="left" valign="top"><paragraph>(11)</paragraph></td><td align="left" valign="top"><paragraph>53</paragraph></td><td align="left" valign="top"><paragraph>(21)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Vomiting</paragraph></td><td align="left" valign="top"><paragraph>24</paragraph></td><td align="left" valign="top"><paragraph>(9)</paragraph></td><td align="left" valign="top"><paragraph>26</paragraph></td><td align="left" valign="top"><paragraph>(11)</paragraph></td><td align="left" valign="top"><paragraph>16</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Cough Increased</paragraph></td><td align="left" valign="top"><paragraph>22</paragraph></td><td align="left" valign="top"><paragraph>(8)</paragraph></td><td align="left" valign="top"><paragraph>18</paragraph></td><td align="left" valign="top"><paragraph>(7)</paragraph></td><td align="left" valign="top"><paragraph>19</paragraph></td><td align="left" valign="top"><paragraph>(8)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Diarrhea</paragraph></td><td align="left" valign="top"><paragraph>22</paragraph></td><td align="left" valign="top"><paragraph>(8)</paragraph></td><td align="left" valign="top"><paragraph>18</paragraph></td><td align="left" valign="top"><paragraph>(7)</paragraph></td><td align="left" valign="top"><paragraph>7</paragraph></td><td align="left" valign="top"><paragraph>(3)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Constipation</paragraph></td><td align="left" valign="top"><paragraph>18</paragraph></td><td align="left" valign="top"><paragraph>(7)</paragraph></td><td align="left" valign="top"><paragraph>18</paragraph></td><td align="left" valign="top"><paragraph>(7)</paragraph></td><td align="left" valign="top"><paragraph>21</paragraph></td><td align="left" valign="top"><paragraph>(8)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Abdominal Pain</paragraph></td><td align="left" valign="top"><paragraph>18</paragraph></td><td align="left" valign="top"><paragraph>(7)</paragraph></td><td align="left" valign="top"><paragraph>14</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td><td align="left" valign="top"><paragraph>18</paragraph></td><td align="left" valign="top"><paragraph>(7)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Anorexia</paragraph></td><td align="left" valign="top"><paragraph>18</paragraph></td><td align="left" valign="top"><paragraph>(7)</paragraph></td><td align="left" valign="top"><paragraph>19</paragraph></td><td align="left" valign="top"><paragraph>(8)</paragraph></td><td align="left" valign="top"><paragraph>11</paragraph></td><td align="left" valign="top"><paragraph>(4)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Bone Pain</paragraph></td><td align="left" valign="top"><paragraph>17</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td><td align="left" valign="top"><paragraph>26</paragraph></td><td align="left" valign="top"><paragraph>(12)</paragraph></td><td align="left" valign="top"><paragraph>19</paragraph></td><td align="left" valign="top"><paragraph>(8)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Pharyngitis</paragraph></td><td align="left" valign="top"><paragraph>16</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td><td align="left" valign="top"><paragraph>23</paragraph></td><td align="left" valign="top"><paragraph>(9)</paragraph></td><td align="left" valign="top"><paragraph>15</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Dizziness</paragraph></td><td align="left" valign="top"><paragraph>16</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td><td align="left" valign="top"><paragraph>12</paragraph></td><td align="left" valign="top"><paragraph>(5)</paragraph></td><td align="left" valign="top"><paragraph>15</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Rash</paragraph></td><td align="left" valign="top"><paragraph>15</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td><td align="left" valign="top"><paragraph>15</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td><td align="left" valign="top"><paragraph>19</paragraph></td><td align="left" valign="top"><paragraph>(8)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Dry Mouth</paragraph></td><td align="left" valign="top"><paragraph>15</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td><td align="left" valign="top"><paragraph>11</paragraph></td><td align="left" valign="top"><paragraph>(4)</paragraph></td><td align="left" valign="top"><paragraph>13</paragraph></td><td align="left" valign="top"><paragraph>(5)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Peripheral Edema</paragraph></td><td align="left" valign="top"><paragraph>14</paragraph></td><td align="left" valign="top"><paragraph>(5)</paragraph></td><td align="left" valign="top"><paragraph>21</paragraph></td><td align="left" valign="top"><paragraph>(9)</paragraph></td><td align="left" valign="top"><paragraph>28</paragraph></td><td align="left" valign="top"><paragraph>(11)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Pelvic Pain</paragraph></td><td align="left" valign="top"><paragraph>14</paragraph></td><td align="left" valign="top"><paragraph>(5)</paragraph></td><td align="left" valign="top"><paragraph>17</paragraph></td><td align="left" valign="top"><paragraph>(7)</paragraph></td><td align="left" valign="top"><paragraph>13</paragraph></td><td align="left" valign="top"><paragraph>(5)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Depression</paragraph></td><td align="left" valign="top"><paragraph>14</paragraph></td><td align="left" valign="top"><paragraph>(5)</paragraph></td><td align="left" valign="top"><paragraph>6</paragraph></td><td align="left" valign="top"><paragraph>(2)</paragraph></td><td align="left" valign="top"><paragraph>5</paragraph></td><td align="left" valign="top"><paragraph>(2)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Chest Pain</paragraph></td><td align="left" valign="top"><paragraph>13</paragraph></td><td align="left" valign="top"><paragraph>(5)</paragraph></td><td align="left" valign="top"><paragraph>18</paragraph></td><td align="left" valign="top"><paragraph>(7)</paragraph></td><td align="left" valign="top"><paragraph>13</paragraph></td><td align="left" valign="top"><paragraph>(5)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Paresthesia</paragraph></td><td align="left" valign="top"><paragraph>12</paragraph></td><td align="left" valign="top"><paragraph>(5)</paragraph></td><td align="left" valign="top"><paragraph>15</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td><td align="left" valign="top"><paragraph>9</paragraph></td><td align="left" valign="top"><paragraph>(4)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Vaginal Hemorrhage</paragraph></td><td align="left" valign="top"><paragraph>6</paragraph></td><td align="left" valign="top"><paragraph>(2)</paragraph></td><td align="left" valign="top"><paragraph>4</paragraph></td><td align="left" valign="top"><paragraph>(2)</paragraph></td><td align="left" valign="top"><paragraph>13</paragraph></td><td align="left" valign="top"><paragraph>(5)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Weight Gain</paragraph></td><td align="left" valign="top"><paragraph>4</paragraph></td><td align="left" valign="top"><paragraph>(2)</paragraph></td><td align="left" valign="top"><paragraph>9</paragraph></td><td align="left" valign="top"><paragraph>(4)</paragraph></td><td align="left" valign="top"><paragraph>30</paragraph></td><td align="left" valign="top"><paragraph>(12)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Sweating</paragraph></td><td align="left" valign="top"><paragraph>4</paragraph></td><td align="left" valign="top"><paragraph>(2)</paragraph></td><td align="left" valign="top"><paragraph>3</paragraph></td><td align="left" valign="top"><paragraph>(1)</paragraph></td><td align="left" valign="top"><paragraph>16</paragraph></td><td align="left" valign="top"><paragraph>(6)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Increased Appetite</paragraph></td><td align="left" valign="top"><paragraph>0</paragraph></td><td align="left" valign="top"><paragraph>(0)</paragraph></td><td align="left" valign="top"><paragraph>1</paragraph></td><td align="left" valign="top"><paragraph>(0)</paragraph></td><td align="left" valign="top"><paragraph>13</paragraph></td><td align="left" valign="top"><paragraph>(5) </paragraph></td></tr></tbody></table>
adverse reactions table
<table width="90%"><caption>Table 6 — Number (n) and Percentage of Patients with Pre-specified Adverse Reactions in Trials 0004 and 0005</caption><col width="20%"/><col width="10%"/><col width="10%"/><col width="10%"/><col width="10%"/><col width="10%"/><col width="10%"/><thead><tr><td align="left" rowspan="3" valign="top"/><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">Anastrozole</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">Anastrozole</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">Megestrol Acetate</content></paragraph></td></tr><tr><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">1 mg</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">10 mg</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">160 mg</content></paragraph></td></tr><tr><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">(N = 262)</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">(N = 246)</content></paragraph></td><td align="left" colspan="2" valign="top"><paragraph><content styleCode="bold">(N = 253)</content></paragraph></td></tr><tr><td align="left" valign="top"><paragraph><content styleCode="bold">Adverse Reaction Group</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">n</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">(%)</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">n</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">(%)</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">n</content></paragraph></td><td align="left" valign="top"><paragraph><content styleCode="bold">(%)</content></paragraph></td></tr></thead><tbody><tr><td align="left" valign="top"><paragraph>Gastrointestinal Disturbance</paragraph></td><td align="left" valign="top"><paragraph>77</paragraph></td><td align="left" valign="top"><paragraph>(29)</paragraph></td><td align="left" valign="top"><paragraph>81</paragraph></td><td align="left" valign="top"><paragraph>(33)</paragraph></td><td align="left" valign="top"><paragraph>54</paragraph></td><td align="left" valign="top"><paragraph>(21)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Hot Flushes</paragraph></td><td align="left" valign="top"><paragraph>33</paragraph></td><td align="left" valign="top"><paragraph>(13)</paragraph></td><td align="left" valign="top"><paragraph>29</paragraph></td><td align="left" valign="top"><paragraph>(12)</paragraph></td><td align="left" valign="top"><paragraph>35</paragraph></td><td align="left" valign="top"><paragraph>(14)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Edema</paragraph></td><td align="left" valign="top"><paragraph>19</paragraph></td><td align="left" valign="top"><paragraph>(7)</paragraph></td><td align="left" valign="top"><paragraph>28</paragraph></td><td align="left" valign="top"><paragraph>(11)</paragraph></td><td align="left" valign="top"><paragraph>35</paragraph></td><td align="left" valign="top"><paragraph>(14)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Thromboembolic Disease</paragraph></td><td align="left" valign="top"><paragraph>9</paragraph></td><td align="left" valign="top"><paragraph>(3)</paragraph></td><td align="left" valign="top"><paragraph>4</paragraph></td><td align="left" valign="top"><paragraph>(2)</paragraph></td><td align="left" valign="top"><paragraph>12</paragraph></td><td align="left" valign="top"><paragraph>(5)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Vaginal Dryness</paragraph></td><td align="left" valign="top"><paragraph>5</paragraph></td><td align="left" valign="top"><paragraph>(2)</paragraph></td><td align="left" valign="top"><paragraph>3</paragraph></td><td align="left" valign="top"><paragraph>(1)</paragraph></td><td align="left" valign="top"><paragraph>2</paragraph></td><td align="left" valign="top"><paragraph>(1)</paragraph></td></tr><tr><td align="left" valign="top"><paragraph>Weight Gain</paragraph></td><td align="left" valign="top"><paragraph>4</paragraph></td><td align="left" valign="top"><paragraph>(2)</paragraph></td><td align="left" valign="top"><paragraph>10</paragraph></td><td align="left" valign="top"><paragraph>(4)</paragraph></td><td align="left" valign="top"><paragraph>30</paragraph></td><td align="left" valign="top"><paragraph>(12)</paragraph></td></tr></tbody></table>
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.